Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 41

Sort by

Sort Order Select

Journal Articles

DNMT3A Mutations Do Not Affect Treatment Response or Outcomes for Patients with Polycythemia Vera Treated with Interferon Alpha

Ghaith Abu-Zeinah, Katie Erdos, Neville Lee, Jr., Richard T. Silver, Joseph M. Scandura

Blood (2024) 144 (Supplement 1): 3190.

https://doi.org/10.1182/blood-2024-210703

Published: 2024

Journal Articles

Deep Learning Predicts JAK2 , Calr TET2 , and ASXL1 directly from Whole Slide Marrow Images

Spencer Krichevsky, Yuwei Zhang, Madhu M Ouseph, Tahmeena Ahmed, Ghaith Abu-Zeinah, Joseph M. Scandura, Rajarsi Gupta

Blood (2024) 144 (Supplement 1): 3600.

https://doi.org/10.1182/blood-2024-208380

Published: 2024

Journal Articles

HOPE-PMF: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Assess Efficacy and Safety of Ropeginterferon Alfa-2b in Patients with Early/Lower-Risk Primary Myelofibrosis

Ghaith Abu-Zeinah, Albert Qin, Harinder Gill, Norio Komatsu, John O. Mascarenhas, Weichung Joe Shih, Oleh Zagrijtschuk, Toshiaki Sato, Kazuya Shimoda, Richard T. Silver, Ruben A. Mesa

Blood (2024) 144 (Supplement 1): 3191.1.

https://doi.org/10.1182/blood-2024-200319

Published: 2024

Journal Articles

Advanced Pulmonary Hypertension Shortens Survival in Polycythemia Vera

Alexander Gazda, Di Pan, Katie Erdos, Ghaith Abu-Zeinah, Alexandra Racanelli, Evelyn Horn, Joseph M. Scandura

Blood (2024) 144 (Supplement 1): 3172.

https://doi.org/10.1182/blood-2024-210231

Published: 2024

Journal Articles

Correlating Image-Level Nucleomorphologic Features with Molecular Subtypes of Myeloproliferative Neoplasms

Spencer Krichevsky, Madhu M Ouseph, Yuwei Zhang, Tahmeena Ahmed, Ghaith Abu-Zeinah, Joseph M. Scandura, Rajarsi Gupta

Blood (2024) 144 (Supplement 1): 3613.

https://doi.org/10.1182/blood-2024-208329

Published: 2024

Journal Articles

MPN Fitness: A Single-Cell, Single-Tube Measurement of the Pathobiology of MPNs

Franco Castillo Tokumori, Daniel C Choi, Ghaith Abu-Zeinah, Nassima Messali, Maria Mia Yabut, Joseph M. Scandura

Blood (2024) 144 (Supplement 1): 1761.

https://doi.org/10.1182/blood-2024-209523

Published: 2024

Journal Articles

Validating the MPN Personalized Risk Calculator in 475 Patients with Polycythemia Vera

Katie Erdos, Neville Lee, Jr., Yushu Shi, Ghaith Abu-Zeinah, Joseph M. Scandura

Blood (2024) 144 (Supplement 1): 4558.

https://doi.org/10.1182/blood-2024-210632

Published: 2024

Journal Articles

Hematopoietic Bias Drives Lymphopenia in Myeloproliferative Neoplasms

Daniel C Choi, Nassima Messali, Ghaith Abu-Zeinah, Pouneh Kermani, Maria Mia Yabut, Franco Castillo Tokumori, Katie Erdos, Joseph M. Scandura, Narasimha Rao Uda, Heidi Lischer, Thomas Lehmann, Marta Sobas, Tata Nageswara Rao

Blood (2024) 144 (Supplement 1): 1764.

https://doi.org/10.1182/blood-2024-212169

Published: 2024

Journal Articles

Outcomes Are Similar for Combination Interferon and Ruxolitinib Versus Ruxolitinib in Myelofibrosis: A Propensity-Score Matched Study

Katie Erdos, Aya Alshareef, Richard T. Silver, Joseph M. Scandura, Ghaith Abu-Zeinah

Blood (2024) 144 (Supplement 1): 1784.

https://doi.org/10.1182/blood-2024-200997

Published: 2024

Journal Articles

Ropeginterferon Alfa-2b (ROPEG) and Peginterferon Alfa-2a (PEG) at Low Dose with Response-Based Titration (LDRT) Have Comparable Efficacy and Tolerability in Polycythemia Vera (PV)

Neville Lee, Jr., Katie Erdos, Aqib Abdul Rahman, Richard T. Silver, Joseph M. Scandura, Ghaith Abu-Zeinah

Blood (2024) 144 (Supplement 1): 4568.

https://doi.org/10.1182/blood-2024-211143

Published: 2024

Journal Articles

Paradigm-PV: A Global, Randomized, Multicenter, Two-Arm Phase IV Study to Assess the Efficacy and Safety of Ropeginterferon Alfa-2b in Low- and High-Risk Patients with Polycythemia Vera

Abdulraheem Yacoub, Ghaith Abu-Zeinah, Albert Qin, Weichung Joe Shih, Waleed Da'na, Tsewang Tashi, Oleh Zagrijtschuk, Robert Geller, Harinder Gill

Blood (2024) 144 (Supplement 1): 6626.

https://doi.org/10.1182/blood-2024-199337

Published: 2024

Journal Articles

Using Machine Learning to Predict Near-Term Thrombosis Risk in Patients with Polycythemia Vera

Spencer Krichevsky, Ghaith Abu-Zeinah, Katie Erdos, Joseph M. Scandura

Blood (2023) 142 (Supplement 1): 3186.

https://doi.org/10.1182/blood-2023-190684

Published: 2023

Journal Articles

JAK2 V617F Impairs Lymphoid Differentiation in Myeloproliferative Neoplasms

Daniel C Choi, Ghaith Abu-Zeinah, Pouneh Kermani, Nassima Messali, Maria Mia Yabut, Katie Erdos, Joseph M. Scandura

Blood (2023) 142 (Supplement 1): 1778.

https://doi.org/10.1182/blood-2023-190758

Published: 2023

Journal Articles

Marrow Hypercellularity Does Not Exclude the Diagnosis of Essential Thrombocythemia (ET)

Katie Erdos, Madhu M Ouseph, Julia Geyer, Neville Lee, Jr., Ghaith Abu-Zeinah, Joseph M. Scandura, Richard T. Silver

Blood (2023) 142 (Supplement 1): 3198.

https://doi.org/10.1182/blood-2023-187769

Published: 2023

Journal Articles

Impact of Graft Source [Cord Blood Supported By CD34+ Selected Cells (Haplo-Cord) Vs. Matched Donor] on Transplant Outcomes in Myelofibrosis

Nima Ghalehsari, Zhengming Chen, Sebastian A. Mayer, Ghaith Abu-Zeinah, Tsiporah B. Shore, Ellen K. Ritchie, Richard T. Silver, Andrew I. Schafer, Joseph M. Scandura, Gail J. Roboz, Koen Van Besien, Alexandra Gomez-Arteaga

Blood (2023) 142 (Supplement 1): 6953.

https://doi.org/10.1182/blood-2023-185075

Published: 2023

Journal Articles

A Deep Learning-Based Pathomics Methodology for Quantifying and Characterizing Nucleated Cells in the Bone Marrow Microenvironment

Spencer Krichevsky, Madhu M Ouseph, Yuwei Zhang, Ghaith Abu-Zeinah, Joseph M. Scandura, Rajarsi Gupta

Blood (2023) 142 (Supplement 1): 2294.

https://doi.org/10.1182/blood-2023-191272

Published: 2023

Journal Articles

Importance of Diagnosing Polycythemia Vera (PV) Patients (pts) Whose Hematocrit (HCT)/Hemoglobin (HGB) Are Less Than the Who 2022 Stipulated Criteria

Neville Lee, Jr., Katie Erdos, Joseph M. Scandura, Ghaith Abu-Zeinah, Richard T. Silver

Blood (2023) 142 (Supplement 1): 6434.

https://doi.org/10.1182/blood-2023-189643

Published: 2023

Journal Articles

Low Thrombosis Risk CALR Mutations Confer Higher Risk of Essential Thrombocythemia Progression

Katie Erdos, Neville Lee, Jr., Ahamed Lebbe, Imane Bouhali, Mohammed Khalid, Ghaith Abu-Zeinah, Richard T. Silver, Joseph M. Scandura

Blood (2023) 142 (Supplement 1): 1819.

https://doi.org/10.1182/blood-2023-188952

Published: 2023

Journal Articles

Safety of Cytoreductive Therapy in Younger Patients with Polycythemia Vera: A Systematic Review and Meta-Analysis

Reem S. Chamseddine, Shehroz Rana, Mohammed Khalid, Nicole Kucine, Richard T. Silver, Joseph Scandura, Ghaith Abu-Zeinah

Blood (2022) 140 (Supplement 1): 3999–4000.

https://doi.org/10.1182/blood-2022-168014

Published: 2022

Journal Articles

JAK2 V617F Impairs T Cell Differentiation in Polycythemia Vera

Daniel C Choi, Ghaith Abu-Zeinah, Silvana Di Giandomenico, Katie Erdos, Joseph Scandura

Blood (2022) 140 (Supplement 1): 6746–6747.

https://doi.org/10.1182/blood-2022-167785

Published: 2022

NARROW

DNMT3A Mutations Do Not Affect Treatment Response or Outcomes for Patients with Polycythemia Vera Treated with Interferon Alpha

Deep Learning Predicts JAK2 , Calr TET2 , and ASXL1 directly from Whole Slide Marrow Images

HOPE-PMF: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Assess Efficacy and Safety of Ropeginterferon Alfa-2b in Patients with Early/Lower-Risk Primary Myelofibrosis

Advanced Pulmonary Hypertension Shortens Survival in Polycythemia Vera

Correlating Image-Level Nucleomorphologic Features with Molecular Subtypes of Myeloproliferative Neoplasms

MPN Fitness: A Single-Cell, Single-Tube Measurement of the Pathobiology of MPNs

Validating the MPN Personalized Risk Calculator in 475 Patients with Polycythemia Vera

Hematopoietic Bias Drives Lymphopenia in Myeloproliferative Neoplasms

Outcomes Are Similar for Combination Interferon and Ruxolitinib Versus Ruxolitinib in Myelofibrosis: A Propensity-Score Matched Study

Ropeginterferon Alfa-2b (ROPEG) and Peginterferon Alfa-2a (PEG) at Low Dose with Response-Based Titration (LDRT) Have Comparable Efficacy and Tolerability in Polycythemia Vera (PV)

Paradigm-PV: A Global, Randomized, Multicenter, Two-Arm Phase IV Study to Assess the Efficacy and Safety of Ropeginterferon Alfa-2b in Low- and High-Risk Patients with Polycythemia Vera

Using Machine Learning to Predict Near-Term Thrombosis Risk in Patients with Polycythemia Vera

JAK2 V617F Impairs Lymphoid Differentiation in Myeloproliferative Neoplasms

Marrow Hypercellularity Does Not Exclude the Diagnosis of Essential Thrombocythemia (ET)

Impact of Graft Source [Cord Blood Supported By CD34+ Selected Cells (Haplo-Cord) Vs. Matched Donor] on Transplant Outcomes in Myelofibrosis

A Deep Learning-Based Pathomics Methodology for Quantifying and Characterizing Nucleated Cells in the Bone Marrow Microenvironment

Importance of Diagnosing Polycythemia Vera (PV) Patients (pts) Whose Hematocrit (HCT)/Hemoglobin (HGB) Are Less Than the Who 2022 Stipulated Criteria

Low Thrombosis Risk CALR Mutations Confer Higher Risk of Essential Thrombocythemia Progression

Safety of Cytoreductive Therapy in Younger Patients with Polycythemia Vera: A Systematic Review and Meta-Analysis

JAK2 V617F Impairs T Cell Differentiation in Polycythemia Vera

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only